Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$62.48T
24h Vol:
$5.91B
Dominance:
MSFT:4.77%
Stocklytics Platform
Instrument logo  JNJ
Johnson & Johnson
JNJ
56 / 100
S&P500
$149.78arrow_drop_up0.44%$0.66

Performance History

Stocklytics logo
Key Stats
Open$149.64
Prev. Close$149.12
EPS7.43
Dividend$4.81
Next Earnings DateSep 3, 2024
Dividend Yield %3.35%
Market Cap$359.34B
PE Ratio20.20
LOWHIGH
Day Range148.21
150.49
52 Week Range143.13
175.97
Ratios
P/B Ratio5.17
Revenue$85.15B
Operating M. %28.80%
Earnings$13.32B
Earnings Growth %-25.72%
EBITDA Margin %36.02%
ROE %18.31%
EPS7.43

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

56vs 54. Market Avg.

All Score 56 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

JNJMARKET
Value4040
Quality5340
Ownership3417
Growth4747
Dividends4338
warning

Johnson & Johnson's Price growth average in the last 3 years of -2.84% is modest compared to market average of 5.25%. This indicates JNJ could be a bad value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$745.16
24H (%)arrow_drop_up1.89%
24H ($)$13.82
MARKET CAP$695.32B
PRICE$486.28
24H (%)arrow_drop_down1.00%
24H ($)-$4.95
MARKET CAP$462.00B
PRICE$126.95
24H (%)0.00%
24H ($)$0.01
MARKET CAP$321.54B
PRICE$169.03
24H (%)arrow_drop_up0.67%
24H ($)$1.14
MARKET CAP$298.54B

About Johnson & Johnson (JNJ)

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Sector
Healthcare
Industry
Drug Manufacturers—General
CEO
Mr. Joaquin Duato
Headquarters
New Brunswick
Employees
152700
Exchange
NYSE
add Johnson & Johnson to watchlist

Keep an eye on Johnson & Johnson

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Johnson & Johnson's (JNJ) price per share?

The current price per share for Johnson & Johnson (JNJ) is $150.05. The stock has seen a price change of $0.93 recently, indicating a 0.62% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Johnson & Johnson (JNJ)?

For Johnson & Johnson (JNJ), the 52-week high is $175.97, which is 17.27% from the current price. The 52-week low is $143.13, the current price is 4.83% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Johnson & Johnson (JNJ) a growth stock?

Johnson & Johnson (JNJ) has shown an average price growth of -2.84% over the past three years. It has received a score of 50 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Johnson & Johnson as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Johnson & Johnson (JNJ) stock price performance year to date (YTD)?

As of the latest data, Johnson & Johnson (JNJ) has a year-to-date price change of -6.21%. Over the past month, the stock has experienced a price change of -3.33%. Over the last three months, the change has been -6.09%. Over the past six months, the figure is -0.87%. Looking at a longer horizon, the five-year price change stands at 7.26%.

help
Is Johnson & Johnson (JNJ) a profitable company?

Johnson & Johnson (JNJ) has a net income of $13.33B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.6% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 28.8% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $85.15B, although specific revenue growth data is currently not available. The gross profit is $58.41B. Operating income is noted at $21.85B. Furthermore, the EBITDA is $33.91B.

help
What is the market capitalization of Johnson & Johnson (JNJ)?

Johnson & Johnson (JNJ) has a market capitalization of $359.35B. The average daily trading volume is 8.75M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.